A new analysis opens the door to discovery of thousands of potential new cancer biomarkers.
New research from the University of Michigan Comprehensive Cancer Center helps explain why pancreatic cancer is so lethal, with fewer than a third of patients surviving even early stage disease.
Sipuleucel-T (trade name Provenge) has been approved since September 2014 for men with metastatic prostate cancer who have few or no symptoms and do not yet require chemotherapy. The German Institute for Quality and Efficiency ...
When metastatic cancer spreads to the spine, it can cause spinal fractures, severe pain and impaired mobility.